Patents/Assignees

Eagle Pharmaceuticals, Inc.

13 patents in portfolio

US12605364utility2026
Methods of Treating Sars-cov-2 Infections
0 cites
US12582633utility2026
Methods of Treating Severe Acute Respiratory Syndrome
0 cites
US12370199utility2025
Fulvestrant Formulations and Methods of Their Use
0 cites
US12350257utility2025
Formulations of Bendamustine
0 cites
US12350339utility2025
Fulvestrant Formulations
0 cites
US12343333utility2025
Formulations of Bendamustine
0 cites
US12186427utility2025
Fulvestrant Formulations and Methods of Their Use
0 cites
US12138248utility2024
Formulations of Bendamustine
0 cites
US12115164utility2024
Pemetrexed Formulations
0 cites
US11872214utility2024
Formulations of Bendamustine
0 cites
US11844783utility2023
Formulations of Bendamustine
0 cites
US11793813utility2023
Pemetrexed Formulations
0 cites
US11590077utility2023
Fulvestrant Formulations and Methods of Their Use
0 cites